Allergy and Immunology

  • Show All

    Faculty

    A photo of J. Pablo Abonia.

    J. Pablo Abonia, MD
    Interim Director, Registry for Eosinophilic Disorders (REGID)

    513-636-9463

    pablo.abonia@cchmc.org

    J. Pablo Abonia, MD

    Interim Director, Registry for Eosinophilic Disorders (REGID)

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-9463

    Fax: 513-636-3310

    Email: pablo.abonia@cchmc.org

    Show All

    Specialties

    Eosinophilic and mast cell disorders; immunodeficiency

    Biography

    J. Pablo Abonia, MD, provides the bulk of the clinical allergy care for patients with eosinophilic disease. He is currently involved in a multicenter clinical research trial of anti-IL5 (reslizumab) for patients with eosinophilic esophagitis. His research focuses on mining the research databanks (patient characteristics, tissue samples, RNA and DNA) to elucidate the mechanisms, diagnosis and treatment of eosinophilic esophagitis, and he is the Interim Director of the Registry for Eosinophilic Disorders (REGID). He is particularly interested in the role of mast cells in eosinophilic esophagitis.

    Education and Training

    MD: University of Buffalo, Buffalo, NY, 1997.

    Residency: Pediatrics, Children's Hospital of Buffalo, Buffalo, NY, 2000.

    Certification: American Board of Pediatrics, 2001; American Board of Allergy and Immunology, 2003.

    Publications

    View PubMed Publications
    A photo of Amal Assa'Ad.

    Amal H. Assa'ad, MD
    Associate Director, Division of Allergy and Immunology

    513-636-6771

    amal.assa'ad@cchmc.org

    Amal H. Assa'ad, MD

    Associate Director, Division of Allergy and Immunology

    Director of Clinical Services, Division of Allergy and Immunology

    Professor, UC Department of Pediatrics

    Phone: 513-636-6771

    Fax: 513-636-4615

    Email: amal.assa'ad@cchmc.org

    Show All

    Specialties

    Food allergy; asthma; vaccine allergy; immunodeficiencies

    Education and Training

    MBBCh (MD): Ain Shams University, Cairo, Egypt 1978.

    MS: Ain Shams University, Cairo, Egypt, 1982.

    Residency: Internal Medicine/Pediatrics, Michigan State University, Hurley Medical Center, Flint, Mich.; Internal Medicine/Pediatrics, Wright State University, Dayton, Ohio, 1990-1992.

    Fellowship:
    Allergy/Clinical Immunology, University of Texas Health Science Center, San Antonio, Texas, 1986-1987; Allergy/Clinical Immunology, Children's Hospital Medical Center, Cincinnati, Ohio, 1992-1995.

    Certification:
    American Board of Internal Medicine, 1992; American Board of Pediatrics, 1992; American Board of Allergy and Immunology, 1995.

    Publications

    View PubMed Publications

    A photo of Lisa Filipovich.

    Alexandra H. Filipovich, MD
    Ralph J. Stolle Chair, Clinical Immunology

    513-803-3218

    lisa.filipovich@cchmc.org

    Alexandra (Lisa) H. Filipovich, MD

    Ralph J. Stolle Chair, Clinical Immunology

    Director, Immune Deficiency and Histiocytosis Program

    Medical Director, Diagnostic Immunology Laboratory

    Professor, UC Department of Pediatrics

    Phone: 513-803-3218

    Fax: 513-636-3549

    Email: lisa.filipovich@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Primary immunodeficiencies; BMT for primary immunodeficiencies; hemophagocytic lymphocytosis; post-BMT immune reconstruction 

    Research Interests

    Biology and genetics of hemophagocytic lymphohistiocytosis; investigation of hematopoietic cell transplantation for genetic immunodeficiencies; immunoreconstitution following pediatric stem cell transplantation 

    Biography

    Lisa Filipovich, MD, began her career at the University of Minnesota where she received her medical degree in 1974 and completed fellowships in both immunopathology and pediatric immunology. She became a professor of pediatrics and served for 10 years as the head of the Division of Immunology at the University of Minnesota Medical School. Dr. Filipovich came to Cincinnati Children’s in 1996. She is currently the Ralph J. Stolle Chair in Clinical Immunology and the director of the Immune Deficiency and Histiocytosis program. She also serves as the medical director of the Diagnostic Immunology Laboratory at Cincinnati Children’s.

    Dr. Filipovich has a special interest in histiocytic disorders, especially hemophagocytic lymphohistiocytosis (HLH). Other interests include bone marrow transplant for primary immune deficiencies and post-BMT immune reconstitution. She serves as president of the Histiocyte Society, an international group of more than 200 physicians and scientists who are committed to improving the lives of patients with histiocytosis through research.

    Education and Training

    MD: University of Minnesota, Minneapolis, MN, 1974.

    Residency: University of Minnesota Hospitals, Minneapolis, MN 1975-1978.

    Fellowship: Immunopathology, Departments of Pediatrics, Laboratory Medicine and Pathology, University of Minnesota 1978-1979.

    Fellowship: Pediatric Immunology, Department of Pediatrics, University of Minnesota 1979-1980.

    Certification: Pediatrics, 1980.

    Publications

    View PubMed Publications

    Grants

    Gene Therapy for SCID-X1 Using Self-Inactivating Gamma. Principal Investigator. National Institutes of Health. Sep 2010 - Aug 2015. #U01 AI 087628.

    Rare Diseases Clinical Consortia for the Rare Diseases. Principal Investigator. National Institutes of Health. Sep 2009 - Aug 2014. #U54 AI 082973.

    Hypoxia and potassium channel activity in T Lymphocytes. Principal Investigator. National Institutes of Health. Jun 2009 - Jun 2014. #R01 CA 095286.

    Histiocyte Society Annual Meeting to be Held in Boston. Principal Investigator. National Institutes of Health. Feb 2011 - Jan 2012. #R13 HL 106925.

    DefaultUser

    Fred Finkelman, MD

    Professor, UC Department of Pediatrics

    Phone: 513-636-6656

    Email: finkelfd@ucmail.uc.edu

    Show All

    Specialties

    Rheumatology; cytokine control of immune-mediated disorders and host protection against parasites, cytokine regulation of allergic disorders, cytokine regulation of lymphopoiesis; regulation of cytokine responses and mechanisms of lymphocyte activation and tolerance; anaphylaxis; transfusion-related acute lung injury

    Publications

    View PubMed Publications

    Grants

    Pathogenesis and prevention of anaphylaxis induced by ingested antigens. Veterans Association. National Institutes of Health. Apr 2008 - Mar 2012.

    IgG isotype regulation of antibody-mediated disorders. Principal Investigator. National Institutes of Health. Oc 2009 - Aug 2012.

    Alternative macrophage activation limits immunopathology. Co-principal Investigator. National Institutes of Health. Dec 2007 - Nov 2012.

    Multidisciplinary clinical research center in Cincinnati Project 2 - Improved understanding of the biology and use of TNF inhibition in JIA. Co-principal Investigator. National Institutes of Health. Apr 2008 - Mar 2013.

    Regulation of CD8+ T cell homeostasis by IL-4. Principal Investigator. National Institutes of Health. Oct 2008 - Dec 2013.

    IL-13 associated eosinophil lung responses. Co-principal Investigator. National Institutes of Health. Jul 2009 - Jun 2014.


    A photo of Tom Fischer.

    Thomas J. Fischer, MD

    513-636-6771

    Thomas J. Fischer, MD

    Adjunct Professor, Allergy and Immunology

    Phone: 513-636-6771

    Fax: 513-636-4615

    Show All

    Specialties

    Pharmacologic management of asthma; immune deficiency diseases

    Education and Training

    MD: University of Cincinnati, Cincinnati, OH, 1971.

    Residency: Children's Hospital Medical Center, Cincinnati, OH.

    Fellowship: Allergy, Children's Hospital Medical Center, Cincinnati, OH; Allergy / Immunology, UCLA Center for the Health Sciences, Los Angeles, CA.

    Certification: Pediatrics, 1976; Allergy/Immunology, 1977; recertification, 1987.

    Publications

    View PubMed Publications

    Patricia C. Fulkerson, MD, PhD

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-803-0973

    Email: patricia.fulkerson@cchmc.org

    Show All

    Specialties

    Eosinophilic disorders; immunodeficiency; immune dysregulation

    Visit the Fulkerson Lab website.

    Biography

    Patricia C. Fulkerson, MD, PhD, is an assistant professor of pediatrics at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine.  Her PhD under the mentorship of Dr. Marc Rothenberg was focused on the analysis of experimental allergic lung inflammation in mice. She made a series of groundbreaking observations including a novel approach to understanding the complex and coordinated interplay of the chemokine family of cytokines and eosinophils in experimental allergic lung disease. Throughout her graduate studies, Dr. Fulkerson was recognized as a top trainee in the laboratory. Nationally, she was selected for competitive awards; her most distinguished award was the Serono Ian Clark-Lewis Memorial Award, provided to a trainee for the best talk at the Keystone Symposium Chemokines & Chemokine Receptors. Locally, she has received several competitive awards and scholarships including the Physician Scientist Training Program Scholar Award, as well as prizes for participation in research forums. Upon completion of the MD/PhD program, Dr. Fulkerson completed a research-track pediatric residency. She was recognized as being an outstanding resident and was awarded the Thomas F. Boat Pediatric Pulmonology Award in her final year of residency.

    Dr. Fulkerson's innovation and dedication to research continued to be recognized during her allergy/immunology fellowship; she received the AAI-Life Technologies Trainee Achievement Award from the American Association of Immunologists in 2011, and she has the distinction of having achieved extramural funding during her first year of clinical fellowship, with the NIH awarding her a K08 grant on her first application. This independent funding at such an early stage is a notable accomplishment. Now, as an assistant professor, Dr. Fulkerson’s independent research program is focused on the biology of the eosinophil lineage-committed progenitor (EoP). Her overall aim is to identify novel therapeutic targets to block eosinophil production for the treatment of patients with eosinophilic disorders. She has developed a number of innovative methods to study the regulation of eosinophil development including liquid culture systems to follow differentiation of both murine and human EoPs into mature effector eosinophils. The pathways that are identified in her culture systems are tested in models of hypereosinophilia, infection, and allergic inflammation to further characterize the clinical and therapeutic potential of candidate targets.

    Education and Training

    MD: Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, 2007.

    PhD: Molecular Genetics, Microbiology & Immunology, University of Cincinnati College of Medicine, Cincinnati, OH, 2005.

    Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.

    Fellowship: Allergy and Immunology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2012.

    Publications

    View PubMed Publications

    Grants

    Role of Spi-C in Eosinophil Development and Functional Responses. Principal Investigator. National Institutes of Health. Apr 2011-Mar 2016. K08 KAI093573A.

    A photo of Gurjit Khurana Hershey.

    Gurjit Khurana Hershey, MD, PhD
    Director, Division of Asthma Research

    513-636-7054

    gurjit.hershey@cchmc.org

    A photo of Gurjit Khurana Hershey.

    Gurjit Khurana Hershey, MD, PhD

    Director, Division of Asthma Research

    Co-Director, Office of Pediatric Clinical Fellowships

    Professor, UC Department of Pediatrics

    Phone: 513-636-7054

    Email: gurjit.hershey@cchmc.org

    Show All

    Specialties

    Clinical

    Asthma; allergic rhinitis; food allergy; urticaria

    Research

    Genetics of allergy and asthma; cytokines; signaling pathways

    Visit the Khurana Hershey Lab

    Biography

    Gurjit Khurana Hershey, MD, PhD, received a BS degree from the University of Iowa, and MD and PhD degrees from Washington University School of Medicine. After completing pediatric residency and an allergy/immunology Fellowship at St. Louis Children’s Hospital, Dr. Khurana Hershey joined the faculty at Cincinnati Children’s Hospital Medical Center. She now directs the Division of Asthma Research at Cincinnati Children’s Hospital Medical Center and is the director of the Medical Scientist Training Program at the University of Cincinnati College of Medicine.

    In addition to her clinical duties, Dr. Khurana Hershey directs an NIH-funded research program focused on the genetics and genomics of allergic inflammation with a focus on cytokines and signal transduction. Her research has been continuously funded for over fifteen years. She is the principal investigator of an NIH-funded Asthma and Allergic Diseases Cooperative Research Center (AADCRC), and is also the PI of the Inner City Asthma Consortium, an NIH funded subcontract. She is the PI of the UC T32 MSTP training grant. In addition to her research contributions, she is an outstanding clinician and teacher/mentor. Several of her trainees now hold academic faculty positions. She is the recipient of the 2013 Cincinnati Children’s Educational Achievement Award.

    Dr. Khurana Hershey is a fellow of the American Pediatric Society and the American Academy of Allergy, Asthma and Immunology. She serves on the Executive Council of the American Academy of Asthma, Allergy and Immunology Program Committee, is the Chair of the Grant Review Committee and appointed Vice Chair of the Basic and Immunology Interest Section. She is a member of the Editorial Board of the Journal of Allergy and Clinical Immunology. She was recently named One of the Five Leading Women in Healthcare in the Greater Cincinnati Metropolitan Area, and Outstanding Woman at Cincinnati Children’s Hospital Medical Center.

    Education and Training

    BS: University of Iowa, Iowa City, IA, 1985.

    PhD: Washington University School of Medicine, St. Louis, MO, 1990.

    MD: Washington University School of Medicine, St. Louis, MO, 1992. 

    Residency: St. Louis Children's Hospital, St. Louis, MO, 1992-1995. 

    Fellowship: St. Louis Children's Hospital, St. Louis, MO, 1995-1997.

    Board Certification: American Board of Pediatrics, 2009 - Present.

    Board Certification: American Board of Allergy and Immunology, 2008 - Present.

    Publications

    View PubMed Publications
    A photo of Simon P. Hogan.

    Simon P. Hogan, PhD
    Director of Research, Division of Allergy and Immunology

    513-636-6620

    simon.hogan@cchmc.org

    Simon P. Hogan, PhD

    Director of Research, Division of Allergy and Immunology

    Director of Admissions, Immunology Graduate Program

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-6620

    Fax: 513-636-3310

    Email: simon.hogan@cchmc.org

    Show All

    Specialties

    Food allergies and anaphylaxis; inflammatory bowel diseases (IBD); innate immunity; gastrointestinal immunity and function; cystic fibrosis (CF)

    Visit the Hogan Lab.

    Education and Training

    BSC: Australian National University, Canberra, Australia, 1998.

    PhD: John Curtin School of Medical Research, Australian National University, Canberra, Australia, 1998.

    Publications

    View PubMed Publications

    Grants

    MiR-375 regulation of CFTR expression and Cl- secretory function. Principal Investigator. Cystic Fibrosis Foundation. Jul 2012-Jun 2014.

    Eosinophil:M2 Macrophage:CCL11 Axis in Experimental Colitis and Pediatric Corticosteroid Resistant UC. Principal Investigator.  National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK). Apr 2012-Mar 2016.

    Epithelial Genes in Allergic Inflammation. Project 2 – Collaborating Investigator. National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAIDS). Sep 2006-Aug 2016.

    Interleukin-9 in Experimental Intestinal Anaphylaxis. Principal Investigator. National Institutes of Health/ National Institute of Allergy and Infectious Diseases/ National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIAIDS/NIDDK). Dec 2007-Nov 2013.


    A photo of Michelle Lierl.

    Michelle B. Lierl, MD
    Clinical Allergist, Division of Allergy and Immunology

    513-636-6771

    michelle.lierl@cchmc.org

    Michelle B. Lierl, MD

    Clinical Allergist, Division of Allergy and Immunology

    Adjunct Professor of Clinical Pediatrics

    Phone: 513-636-6771

    Fax: 513-636-4615

    Email: michelle.lierl@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Treatment and prevention of asthma; allergic rhinitis; allergen immunotherapy; eczema; food allergy; anaphylaxis; suspected immune deficiency

    Research Interests

    Role of environmental allergens and pollutants in childhood asthma; allergen immunotherapy; asthma pathogenesis and treatment; role of outdoor fungal spores as aeroallergens; diagnosis and treatment of food allergy

    Visit Dr. Lierl's fungal spore photo website.

    Visit the Lierl Lab website.

    Biography

    Michelle B. Lierl, MD, is board-certified in Pediatrics, Pediatric Pulmonary Medicine and Allergy / Immunology. Dr. Lierl's primary clinical interests are diagnosis and treatment of asthma, allergic rhinitis, chronic cough, food, latex, insect venom and drug allergies, and eczema.

    Dr. Lierl has been treating allergy patients in the Allergy Clinic and Asthma Center, which provides state-of-the-art diagnosis and treatment of asthma and allergies, as well as comprehensive patient education regarding these diseases. She has developed community outreach and patient / family education programs for urban children with asthma and their families.

    Dr. Lierl also helps staff the Allergy inpatient service, which provides consultation for the management of patients with difficult-to-manage asthma, suspected drug allergies, anaphylaxis, or suspected immune deficiency.

    Education and Training

    MD: University of Kentucky College of Medicine, Lexington, KY, 1979.

    Residency: University of Kentucky Medical Center, Lexington, KY, 1979 to 1982. 

    Fellowship: Pediatric Pulmonary Medicine, Louisiana State University Medical Center, Shreveport, LA, 1984 - 1986; Allergy / Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 1986 - 1988. 

    Certification: Pediatrics, 1984; Allergy / Immunology, 1987; Pediatric Pulmonary, 1989, 1996, 2002.

    Publications

    View PubMed Publications
    A photo of Kimberly Risma.

    Kimberly A. Risma, MD, PhD
    Director, Allergy and Immunology Fellowship Program

    513-636-6771

    kimberly.risma@cchmc.org

    Kimberly A. Risma, MD, PhD

    Director, Allergy and Immunology Fellowship Program

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-636-6771

    Fax: 513-636-4615

    Email: kimberly.risma@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Immune deficiency; immune dysregulation

    Research Interests

    Pathophysiology of perforin missense mutations identified in individuals with hemophagocytic lymphohistiocytosis; molecular mechanisms of primary immune deficiency and dysregulation; natural killer cell and cytotoxic T lymphocyte cytotoxicity

    Visit the Risma Lab website.

    Biography

    Kimberly Risma, MD, PhD, is an assistant professor in the Division of Allergy and Immunology at Cincinnati Children’s and the University of Cincinnati College of Medicine.

    Dr. Risma graduated magna cum laude with a Bachelor of Arts in Chemistry from Duke University in 1990 and was elected into The Phi Beta Kappa Society. She then matriculated at Case Western Reserve University (CWRU) School of Medicine in the Medical Scientist Training Program (MSTP). In 1996, she completed a PhD in pharmacology. She was selected by the leadership of the CWRU MSTP as the recipient of the 1997 Martin Wahl Memorial Fund Award, given annually to recognize the graduating MD, PhD student who has demonstrated the highest level of independence in research and excellence in research and clinical skills. She was also elected to Alpha Omega Alpha Society in 1997.

    In 1997, she enrolled in a Pediatrics residency at Cincinnati Children’s Hospital Medical Center/University of Cincinnati.  During the residency program, Dr. Risma was awarded the pediatric resident teaching award by the medical students. She also engaged in translational research studies related to the genetics of asthma under the mentorship of Dr. Gurjit Hershey, resulting in a first author publication as a pediatric resident.

    In 2000, Dr. Risma was accepted to the Allergy and Immunology Fellowship Program at Cincinnati Children’s.  In addition to her clinical training, she pursued an innovative research project under the mentorship of Dr. Janos Sumegi and Dr. Alexandra Filipovich. She proposed a mechanism to study the structural and functional impact of perforin missense mutations identified in patients with hemophagocytic lymphohistiocytosis. In 2004 she was awarded the Nezelof Prize for best scientific presentation at the international meeting of the Histiocyte Society. The culmination of her fellowship research project was published in the Journal of Clinical Investigation, 2006.  

    Upon completion of her fellowship in 2005, Dr. Risma was appointed as an Assistant Professor in the Division of Allergy and Immunology at Cincinnati Children’s Hospital Medical Center. In 2006 Dr. Risma received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation. Dr. Risma is the director of the Allergy and Immunology Fellowship Program at Cincinnati Children's, having served in this leadership position since August of 2012.

    Dr. Risma's research program focuses on understanding the molecular mechanisms of immunodeficiency and immune dysregulation in children, especially as it relates to disorders of lymphocyte cytotoxicity. In addition to her research, she sees patients from all around the country in consultation for primary immune deficiency, immune dysregulation, and allergic disorders.   

    Education and Training

    MD: Case Western Reserve University School of Medicine, Cleveland, OH, 1997.

    PhD: Case Western Reserve University School of Medicine, Cleveland, OH, 1996.

    Residency: Pediatrics, Cincinnati Children's Hospital Medical Center, 1997-2000.

    Fellowship: Allergy / Immunology, Cincinnati Children's Hospital Medical Center.

    Certification: Pediatrics, 2007; Allergy and Immunology, 2005.

    Publications

    View PubMed Publications

    A photo of Marc Rothenberg, MD, PhD.

    Marc E. Rothenberg, MD, PhD
    Director, Division of Allergy and Immunology

    513-803-0257

    marc.rothenberg@cchmc.org

    Marc E. Rothenberg, MD, PhD

    Director, Division of Allergy and Immunology

    Director, Cincinnati Center for Eosinophilic Disorders

    Program Director, CHRCDA (K12)

    Professor, UC Department of Pediatrics

    Phone: 513-803-0257

    Fax: 513-636-3310

    Email: marc.rothenberg@cchmc.org

    Show All

    Specialties

    Clinical Interests

    Eosinophilia; eosinophilic disorders; asthma; allergy; food allergy

    Research Interests

    Eosinophils; chemokines

    Visit the Rothenberg Lab.

    Biography

    Marc E. Rothenberg, MD, PhD, is the Director of the Division of Allergy and Immunology at Cincinnati Children's Hospital Medical Center, and a tenured Professor of Pediatrics at Cincinnati Children’s and the University of Cincinnati College of Medicine. He graduated summa cum laude with Highest Honors in Chemistry and Biochemistry from Brandeis University. He then matriculated at Harvard Medical School in the combined MD / PhD program. His PhD under the mentorship of Dr. Frank Austen included seminal studies on eosinophil hematopoiesis, as he developed the first culture system for human eosinophils.

    After completing a two-year residency in pediatrics at Children’s Hospital in Boston, Dr. Rothenberg did a combined fellowship in allergy / immunology and hematology at Children’s Hospital in Boston. During this fellowship program, Dr. Rothenberg did post-doctorate training in the genetics laboratory of Dr. Philip Leder at Harvard Medical School, where he cloned the eotaxin chemokine. After being on faculty of Harvard Medical School for one year, he came to the University of Cincinnati and Cincinnati Children's, one of the largest pediatric medical and research centers in the United States. He is actively involved in managing a research program focused on understanding the molecular mechanisms of allergic disorders. At Cincinnati Children’s, he has helped build a top program in pediatric research, and his division is a leader in pediatric allergy and immunology. In addition, he sees patients suffering from allergic and immunological diseases from around the world as part of the Cincinnati Center for Eosinophilic Disorders that he directs.

    Dr. Rothenberg’s awards include the Pharmacia Allergy Research Foundation Award for the best young investigator in the allergy field; the Young Investigator Award and the Scholar in Allergy Award from the American Academy of Allergy, Asthma, and Immunology; the Ohio Governor’s Recognition Award; the 2007 E Mead Johnson Award from the Society of Pediatric Research; and an NIH MERIT Award in 2010 from the NIAID. He is an elected member of the American Society of Clinical Investigation, Society for Pediatric Research, and a Diplomate of the American Academy of Allergy, Asthma and Immunology.

    Among his extensive publications of more than 250 articles on molecular mechanisms of allergic responses, Dr. Rothenberg edited a book entitled, “Chemokines in Allergic Disease”. He has served on various review panels for journals and grant agencies including the National Institutes of Health, where he served on the Advisory Council of the NIAID, Burroughs Trust, and the Medical Research Council of the UK. His research has been supported by numerous sources including the National Institutes of Health, the USA Department of Defense, Human Frontier Science Program Organization, the Burroughs Wellcome Fund, the Dana Foundation, and the Food Allergy and Anaphylaxis Network.

    Visit the Rothenberg Lab website

    Education and Training

    MD, PhD: Harvard Medical School, Cambridge, MA, 1990.

    Residency: Pediatrics, Children's Hospital, Boston, MA, 1991-1992.

    Fellowship: Immunology / Allergy, Children's Hospital, Boston, MA, 1992-1994; Hematology / Oncology, Children's Hospital and Dana Farber Cancer Institute, Boston, MA, 1992-1995.

    Certification: National Board of Medical Examiners, 1991; Board of Registration in Medicine, MA, 1992; American Board of Pediatrics, 1995, 2001, 2008; Ohio State Medical Board, 1997; American Board of Allergy and Immunology, 1997, 2006.

    Publications

    Grants

    NICHHD Pediatric Center for Gene Expression and Developmental Sciences. Program Director. National Institutes of Health. 2007-2011. K12 HD028827.

    IL-13 and Eosinophilic Esophagitis. Principal Investigator. National Institutes of Health.  2007-2012. R01 DK076893.

    Genetics of Eosinophilic Esophagitis. Principal Investigator. Department of Defense. 2010-2012. DOD W81XWH1010167. 

    Resistin-like Molecules in the Lung. Co-Principal Investigator. US-Israel Binational Science Foundation. 2010-2012. #2009222. 

    IL-13 Associated Eosinophil Lung Responses. Principal Investigator. National Institutes of Health. 2009-2014. R01 AI083450.

    Regulation of Gastrointestinal Eosinophils. Principal Investigator. National Institutes of Health. 2009-2014. R37 AI045898. 

    Yui-Hsi Wang, PhD

    Assistant Professor, UC Department of Pediatrics

    Phone: 513-803-2193

    Fax: 513-636-3310

    Email: yui_hsi.wang@cchmc.org

    Show All

    Specialties

    Asthma; food allergy; T cell biology

    Education and Training

    PhD: University of Alabama, Birmingham, AL, 2001.

    Publications

    View PubMed Publications

    Grants

    The roles of IL-17-producing TH2 memory/effector cells in allergic asthma. Principal Investigator. American Lung Association. July 2010 - June 2012. #AI-169584-N.

    Regulation and maintenance of TH2 memory/effector cells. Principal Investigator. National Institutes of Health. May 2010- April 2015. #R01AI090129-01.


    A photo of Nives Zimmermann.

    Nives Zimmermann, MD
    Director of MS Track, Immunology Graduate Program

    513-636-3887

    nives.zimmermann@cchmc.org

    Nives Zimmermann, MD

    Director of MS Track, Immunology Graduate Program

    Associate Professor, UC Department of Pediatrics

    Phone: 513-636-3887

    Fax: 513-636-3310

    Email: nives.zimmermann@cchmc.org

    Show All

    Specialties

    Asthma; allergy; eosinophils; lung inflammation

    Visit the Zimermann Lab.

    Education and Training

    MD: School of Medicine, University of Zagreb; Zagreb, Croatia, 1995.

    Publications

    View PubMed Publications